INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹142 Cr | ₹155 Cr | ₹93 Cr | ₹24 Cr | ₹-2.90 Cr |
What is the latest Consolidated Net Profit of INDOCO REMEDIES ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹142 Cr |
Mar2023 | ₹155 Cr |
Mar2022 | ₹93 Cr |
Mar2021 | ₹24 Cr |
Mar2020 | ₹-2.90 Cr |
How is Consolidated Net Profit of INDOCO REMEDIES Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹142 Cr | -8.11 | |
Mar2023 | ₹155 Cr | 66.37 | |
Mar2022 | ₹93 Cr | 285.81 | |
Mar2021 | ₹24 Cr | Positive | |
Mar2020 | ₹-2.90 Cr | - |
Compare Consolidated Net Profit of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,004.8 Cr | -1% | 16.4% | -3.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -1% |
16.4% |
-3.9% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses